Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback